4Herrmann R, Bodoky G, Ruhstaller T, et al. Gemeitabine plus capecitabine compared with gemeitabine alone in advanced pancreatic cancer:a randomized, muhicenter, phase Ⅲ trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group[J]. J Clin Oncol, 2007, 25(16):2212-2217. 被引量：1
5Heinemann V, Quietzsch D, Gieseler F, et al. Randomized phase Ⅲ trial of gemcitabine plus cisplatin with gemcitabine alone in advanced pancreatic carcinoma[J]. J Clin Oncol, 2006, 24(24):3946-3952. 被引量：1
6Tempero M,Plunkett W, Ruiz Van Haperen V, et al. Randomized phase Ⅱ comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma[J]. J Clin Oncol,2003, 21 (18):3402-3408. 被引量：1
7Maurel J, Zorrilla M, Puertolas T, et al. Phase Ⅰ trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors [J]. Anticancer Drugs, 2001,12(9):713-717. 被引量：1
8Spath-Sehwalbe E, Genvresse I, Kosehuth A, et al. Phase Ⅱ trial of gemeitabine in patients with pretreated advanced soft tissue sareomas[J]. Antieaneer Drugs, 2000, 11(5):325-329. 被引量：1
9Soo RA, Wang LZ, Tham LS, et al. A multicentre randomised phase Ⅱ study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer[J]. Ann Oncol, 2006, 17(7):1128-1133. 被引量：1
10Shin SJ, Kim H, Baek JH, et al. Prospective phase Ⅱ trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma [J]. Lung Cancer, 2008, 60(1):83-91. 被引量：1
